Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Veru
AddedFeb 19, 2024
UpdatedJun 18, 2026
Veru

Veru

Public

Veru: An oncology biopharmaceutical firm innovating novel treatments for prostate and breast cancers.

HQ
Miami, FL, US
Founded
2016
Overview
Compare
Fundraising
Employees
Website

Veru, founded as an oncology biopharmaceutical company, aims to innovate novel treatments for prostate and breast cancers. The company's mission is to develop and commercialize high-quality therapies that address significant medical needs, including weight loss and viral-related ARDS. Veru's core products include a selective androgen receptor modulator (SARM) designed to mitigate muscle loss in patients undergoing weight loss therapy with GLP- drugs.

Notable individuals affiliated with Veru include its leadership team, composed of experienced professionals in the biopharmaceutical industry. The company has garnered investment from key stakeholders committed to advancing oncology treatments. Veru's significant achievements include the development of promising therapies that have the potential to transform cancer treatment paradigms. Its impact is marked by a commitment to improving patient outcomes in oncology and related fields.

Veru - Similar Companies

Verastem logo

Verastem

Verrica Pharmaceuticals logo

Verrica Pharmaceuticals

verrica.com

Revolution Medicines logo

Revolution Medicines

revmed.com

Vero Biotech logo

Vero Biotech

vero-biotech.com

Vyriad logo

Vyriad

vyriad.com

Verseau Therapeutics logo

Verseau Therapeutics

verseautx.com

Veralox Therapeutics logo

Veralox Therapeutics

veralox.com

Clovis Oncology logo

Clovis Oncology

OnCusp Therapeutics logo

OnCusp Therapeutics

oncusptx.com

Verda Bio logo

Verda Bio

verdabio.com

Novocure logo

Novocure

novocure.com

Elevar Therapeutics logo

Elevar Therapeutics

Verix Health logo

Verix Health

ReveraGen BioPharma logo

ReveraGen BioPharma

reveragen.com

Veracyte logo

Veracyte

veracyte.com

Veru - Quick Facts

Who are Veru's competitors?

Companies similar to Veru include Verastem, Verrica Pharmaceuticals, Revolution Medicines and Vero Biotech.

When was Veru founded?

Veru was founded in 2016.

Where is Veru's headquarters located?

Veru's headquarters is located in Miami, FL, US.

When was Veru's last funding round?

Veru's most recent funding round was for $33M (USD) in December 2023.

How much has Veru raised to-date?

As of Dec 14, 2023, Veru has raised a total of $133M (USD).

How many employees does Veru have?

Veru has 375 employees as of Feb 6, 2024.

Veru - Classification

Ownership
  • Public
Technology
  • Biotech
Geographic Exposure
  • Global
Revenue
  • Recurring
  • Software
Customer
  • Enterprise
Main Product
  • Cancer Treatments
  • Pharmaceuticals
Tags
  • Healthcare
  • Healthtech
Unique IDs
  • ein: 391144397
  • secCik: 0000863894
  • ticker: VERU
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 541000Professional, Scientific, and Technical Services
  • 541700Scientific Research and Development Services
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
SIC
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 8730Research, Development, And Testing Services
  • 8731Commercial Physical and Biological Research
ISIC
  • 2100Manufacture of pharmaceuticals, medicinal chemical and botanical products
Show 16 more industry codes
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 620000Health Care and Social Assistance
  • 325000Chemical Manufacturing
  • 623000Nursing and Residential Care Facilities
  • 325410Pharmaceutical and Medicine Manufacturing
  • 325412Pharmaceutical Preparation Manufacturing
SIC
  • 3000Rubber And Miscellaneous Plastics Products
  • 3060Fabricated Rubber Products, Not Elsewhere Classified
  • 2800Chemicals And Allied Products
  • 4000Railroad Transportation
  • 8000Health Services
  • 2830Drugs
  • 8040Offices And Clinics Of Other Health Practitioners
  • 2834Pharmaceutical Preparations
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified